Gelonghui reported on December 13 that Shenzhen Salubris Pharmaceuticals (002294.SZ) recently stated in an investor relations activity that some small nucleic acid projects are in preclinical research, and further R&D progress will be announced in due course.
- Headlines
- Shenzhen Salubris Pharmaceuticals (002294.SZ): Some small nucleic acid projects will be in preclinical research next year.
信立泰(002294.SZ)：明年有部分小核酸项目在临床前研究中
Shenzhen Salubris Pharmaceuticals (002294.SZ): Some small nucleic acid projects will be in preclinical research next year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Log In for the Full List
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.